Echo Research Launches Online Automated Media Analysis System

New York, NY, October 14, 2009 -- Echo Research today announced the launch of its new online media analysis system – Echo Sonar. Echo Sonar is a significant advancement in automated media analysis because of its access to publications around the world and its advanced analytic platform.

Echo's survey for The Guardian helps challenge negative stereotypes of teenage boys...

Getting the media low down

Medics on the Move claim they take the hassle out of finding homes, and when property adviser Jenny Gee wanted to take the hassle out of evaluating the media, she chose Echo Sonar.
 
2008 | 2007 | 2006 | 2005 | 2004


June 02, 2006
MHRA investigation into 'elephant man' drug trail

Organisation: Parexel

Analysis and commentary by Echo Research.

Click here for full-size graph

Last week's publication of the official report into the 'elephant man' drug trials brought scant comfort to Parexel, the organisation behind the "disastrous" (Guardian, 26/5) testing of drug TGN1412. Finding that the negative effects of the drug, which left six healthy adults with mutiple organ failure and swelling, were due to an unexpected biological effect rather than any error by Parexel, the report criticised sloppy administration procedures, a lack of adequate training and experience of staff, no 24 hour cover, inadequate insurance cover and a delay in appropriate counter treatment.

Damming, but not enough for the claimants' solicitors, who branded the investigation a sham and claimed the next day's headlines: "Victims fury over elephant drug 'whitewash" (Daily Mirror, 26/5); "Drug test review is 'whitewash'" (Daily Telegraph, 26/5). Central to criticism was that the investigation had been undertaken by the MHRA, the drug industry's own watchdog, with inevitable question marks over its impartiality. "Today's report is inadequate and completely misses the point" was an independent drug expert's view (bbc.co.uk, 25/5). With calls for an independent review of the MHRA, it seems that the side effects from this ill-fated drugs trial will be felt by victims and industry alike for some time to come.

<< See All Press Releases
 
Copyright 2006 Echo Research
 
 

PR Week Echo Columns